3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Leukemia, Myeloid, Acute
12
Myelodysplastic Syndromes
8
Leukemia
8
Myeloproliferative Disorders
6
Lymphoma, Non-Hodgkin
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Recurrence
5
Primary Myelofibrosis
5
Lymphoma, T-Cell
5
Lymphoma
5
Hodgkin Disease
5
Multiple Myeloma
4
Graft vs Host Disease
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Follicular
3
Leukemia, Prolymphocytic, T-Cell
3
Leukemia, Myelomonocytic, Chronic
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, T-Cell, Peripheral
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Myeloid, Accelerated Phase
2
Burkitt Lymphoma
2
Breast Neoplasms
2
Interventions
Etoposide
4
pegaspargase
3
Cyclophosphamide
3
Methylprednisolone
2
Gemcitabine
2
Flow Cytometry
2
Dexamethasone
2
Alemtuzumab
2
zanubrutinib
1
sintilimab
1
ruxolitinib
1
fludarabine phosphate
1
fludarabine
1
Whole-Body Irradiation
1
Vincristine
1
Thiotepa
1
Th1-Th2 Balance
1
Tacrolimus
1
Rituximab
1
Prednisone
1
Polymerase Chain Reaction
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Methylprednisolone Hemisuccinate
1
Melphalan
1
In Situ Hybridization
1
Immunohistochemistry
1
EPOCH protocol
1
Doxorubicin
1
Cytogenetic Analysis
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphohistiocytosis, Hemophagocytic
×
ruxolitinib
×
Lymphoid
×
Clear all
NCT04999878
2021-08-11
RUE-DDGP
Zhengzhou University
Phase 4
Unknown
30 enrolled